基本信息
浏览量:8
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
Prof Clarke previously spent six years engaged in health economic research at the University of Oxford. His research in Oxford focused on the economic analysis of the United Kingdom Prospective Diabetes Study (UKPDS) – a landmark trial of policies to improve the management of people with Type 2 diabetes.
His health economic research interests include developing methods to value the benefits of improving access to health care, health inequalities and the use of simulation models in health economic evaluation. He has also undertaken policy relevant research for the World Bank, OECD, AusAID and DoHA.
He has over 80 peered review publications and has recently contributed to books on cost-effectiveness analysis and cost-benefit analysis published by Oxford University Press.
His health economic research interests include developing methods to value the benefits of improving access to health care, health inequalities and the use of simulation models in health economic evaluation. He has also undertaken policy relevant research for the World Bank, OECD, AusAID and DoHA.
He has over 80 peered review publications and has recently contributed to books on cost-effectiveness analysis and cost-benefit analysis published by Oxford University Press.
研究兴趣
论文共 302 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
SOCIAL SCIENCE & MEDICINE (2024): 116426-116426
PharmacoEconomics (2024)
Cost Effectiveness and Resource Allocationno. 1 (2024): 1-11
medrxiv(2024)
PharmacoEconomicspp.1-12, (2024)
The Lancet Diabetes & Endocrinologyno. 7 (2024): 462-471
crossref(2024)
Raymond Duch,Edward Asiedu,Ryota Nakamura,Thomas Rouyard, Alberto Mayol,Adrian Barnett,Laurence Roope,Mara Violato, Dorcas Sowah,Piotr Kotlarz,Philip Clarke
Nature Medicineno. 3 (2024): 905-905
The Lancet (2024)
DIABETES RESEARCH AND CLINICAL PRACTICE (2023): 110944-110944
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn